http://dbpedia.org/ontology/abstract
|
La Chugai, chiamata ufficialmente Chugai P … La Chugai, chiamata ufficialmente Chugai Pharmaceutical Co. (中外 製 薬 株式会社 Chūgai Seiyaku Kabushikigaisha?), è una società giapponese produttrice di farmaci quotata alla borsa di Tokyo. È una filiale controllata dalla Hoffmann–La Roche, che dal 30 giugno 2014 detiene il 62% della società. giugno 2014 detiene il 62% della società.
, 中外製薬株式会社(ちゅうがいせいやく、英: CHUGAI PHARMACEUTICAL CO.,LTD.)は、日本の大手医薬品メーカーである。日経平均株価およびTOPIX Large70の構成銘柄の一つ。
, Chugai Pharmaceutical Co., Ltd. (jap. 中外製薬) – jeden z największych japońskich koncernów farmaceutycznych. 51,5% udziałów firmy należy do Hoffmann-La Roche. Koncern powstał w marcu 1943 roku.
, 주가이 제약 주식회사(일본어: 中外製薬株式会社, ちゅうがいせいやく)는 일본의 대형 제약 기업이며, 의약품 개발과 제조 및 수입한다.
, Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社 Chūgai Seiyaku Kabushikigaisha?) é uma companhia farmacêutica japonesa, sediada em Tóquio.
, 中外製藥(日语:中外製薬/ちゅうがいせいやく Chūgai seiyaku */?)是一家日本製藥公司,目前為跨國藥廠羅氏的子公司。
, Chūgai Seiyaku Kabushiki kaisha (jap. 中外製薬 … Chūgai Seiyaku Kabushiki kaisha (jap. 中外製薬株式会社; engl. Chugai Pharmaceutical Co., Ltd.) ist ein 1925 in Tokio gegründetes japanisches Pharmaunternehmen. Es ist im Nikkei 225 gelistet. Der registrierte Unternehmenssitz ist Kita, der tatsächliche Chūō. Seit 1998 ist das Unternehmen auf dem deutschen Markt in den Bereichen Hämatologie und Onkologie tätig. Die bekanntesten Produkte sind Epogin (Erythropoietin) und Granocyte (G-CSF), im Jahr 2010 übernahm die Firma auch den Vertrieb von Capecitabin (Xeloda®). 2002 fusionierte Chugai mit Roche Nippon und wurde dadurch zum fünftgrößten Pharmaunternehmen in Japan. Im Juni 2014 hielt die Roche Holding einen Anteil von rund 62 %. Roche Holding einen Anteil von rund 62 %.
, Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社 … Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社 Chūgai Seiyaku kabushiki gaisha) adalah produsen obat-obatan yang beroperasi di Jepang. Chugai adalah anak perusahaan yang dikendalikan oleh Hoffmann-La Roche, yang memiliki 62% saham perusahaan tersebut pada 30 Juni 2014. Perusahaan ini berkantor pusat di Tokyo. adalah direktur perwakilan dan ketua saat ini. Tatsuro Kosaka adalah direktur perwakilan, presiden, dan direktur utama saat ini.an, presiden, dan direktur utama saat ini.
, Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, … Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.epresentative director, president and CEO.
, Chugai Pharmaceutical Co., Ltd. (яп. 中外 製 … Chugai Pharmaceutical Co., Ltd. (яп. 中外 製 薬 株式会社 Chūgai Seiyaku: кабусики-гайся) — японская фармацевтическая компания. Это дочерняя компания, контролируемая Hoffmann-La Roche, которой по состоянию на 30 июня 2014 года принадлежало 62% акции компании. Головной офис компании находится в Токио. Осаму Нагаяма – нынешний представитель директора и председатель. Тацуро Косака – нынешний представитель директора, президент и генеральный директор.ректора, президент и генеральный директор.
|
http://dbpedia.org/ontology/foundingDate
|
"1943-03-08"^^xsd:date
|
http://dbpedia.org/ontology/foundingYear
|
1943
|
http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Osamu_Nagayama +
|
http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Ch%C5%AB%C5%8D%2C_Tokyo +
|
http://dbpedia.org/ontology/originalName
|
中外製薬株式会社
|
http://dbpedia.org/ontology/parentCompany
|
http://dbpedia.org/resource/Hoffmann-La_Roche +
|
http://dbpedia.org/ontology/revenue
|
3.448E11
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Chugai_Pharmaceutical.svg?width=300 +
|
http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.chugai-health.com/Healthcare +
, http://www.chugai-pharm.co.jp/english/index.html +
|
http://dbpedia.org/ontology/wikiPageID
|
15996127
|
http://dbpedia.org/ontology/wikiPageLength
|
6780
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1094399699
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Neuromyelitis_optica +
, http://dbpedia.org/resource/Chemotherapy +
, http://dbpedia.org/resource/Granisetron +
, http://dbpedia.org/resource/Category:Roche +
, http://dbpedia.org/resource/Athersys +
, http://dbpedia.org/resource/Human_immunodeficiency_virus +
, http://dbpedia.org/resource/Biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area +
, http://dbpedia.org/resource/Kabushiki_gaisha +
, http://dbpedia.org/resource/Category:Japanese_companies_established_in_1943 +
, http://dbpedia.org/resource/Satralizumab +
, http://dbpedia.org/resource/Leukemia +
, http://dbpedia.org/resource/Influenza_virus +
, http://dbpedia.org/resource/Oseltamivir +
, http://dbpedia.org/resource/Ch%C5%AB%C5%8D%2C_Tokyo +
, http://dbpedia.org/resource/Ischemic_stroke +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Tokyo_Stock_Exchange +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Japan +
, http://dbpedia.org/resource/Antiemetic +
, http://dbpedia.org/resource/Hoffmann-La_Roche +
, http://dbpedia.org/resource/Saquinavir +
, http://dbpedia.org/resource/Nikkei_225 +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Mycophenolate_mofetil +
, http://dbpedia.org/resource/Tocilizumab +
, http://dbpedia.org/resource/Immunosuppressive +
, http://dbpedia.org/resource/Category:Orphan_drug_companies +
, http://dbpedia.org/resource/Category:Manufacturing_companies_based_in_Tokyo +
, http://dbpedia.org/resource/Zalcitabine +
, http://dbpedia.org/resource/Osamu_Nagayama +
, http://dbpedia.org/resource/Stem-cell_therapy +
, http://dbpedia.org/resource/Category:1943_establishments_in_Japan +
, http://dbpedia.org/resource/Tretinoin +
, http://dbpedia.org/resource/Vitamin_A +
, http://dbpedia.org/resource/Orphan_disease +
|
http://dbpedia.org/property/founded
|
"1943-03-08"^^xsd:date
|
http://dbpedia.org/property/imageCaption
|
Headquarters in Nihonbashi Mitsui Tower
|
http://dbpedia.org/property/industry
|
Pharmaceutical Industry, Business import, production and development of drugs for medical sales
|
http://dbpedia.org/property/keyPeople
|
Osamu Nagayama - Chairman and Tatsuro Kosaka - CEO
|
http://dbpedia.org/property/location
|
On the registration Headquarter: Tokyo Kita
, Nihonbashi Mitsui Tower, Nihonbashi Muromachi 2-1-1, Chūō, Tokyo
|
http://dbpedia.org/property/logo
|
Chugai Pharmaceutical.svg
|
http://dbpedia.org/property/name
|
Chugai Pharmaceutical Co., Ltd.
|
http://dbpedia.org/property/nativeName
|
中外製薬株式会社
|
http://dbpedia.org/property/nativeNameLang
|
ja
|
http://dbpedia.org/property/parent
|
http://dbpedia.org/resource/Hoffmann-La_Roche +
|
http://dbpedia.org/property/revenue
|
72900000000
|
http://dbpedia.org/property/romanizedName
|
Chūgai Seiyaku kabushiki gaisha
|
http://dbpedia.org/property/tradedAs
|
Nikkei 225 component
|
http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Kabushiki_gaisha +
, http://dbpedia.org/resource/Public_company +
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Nihongo +
, http://dbpedia.org/resource/Template:Dead_link +
, http://dbpedia.org/resource/Template:Tyo +
, http://dbpedia.org/resource/Template:Nikkei_225 +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Url +
, http://dbpedia.org/resource/Template:Japan-company-stub +
, http://dbpedia.org/resource/Template:Commons_category +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
|
http://dbpedia.org/property/wordnet type
|
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Roche +
, http://dbpedia.org/resource/Category:Manufacturing_companies_based_in_Tokyo +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Japan +
, http://dbpedia.org/resource/Category:Japanese_companies_established_in_1943 +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Tokyo_Stock_Exchange +
, http://dbpedia.org/resource/Category:1943_establishments_in_Japan +
, http://dbpedia.org/resource/Category:Orphan_drug_companies +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Manufacturer +
|
http://schema.org/sameAs
|
http://viaf.org/viaf/312912422 +
|
http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.418587.7 +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Chugai_Pharmaceutical_Co.?oldid=1094399699&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Chugai_Pharmaceutical.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Nihonbashi_mitsui_tower01s3872.jpg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Chugai_Pharmaceutical_Co. +
|
http://xmlns.com/foaf/0.1/name
|
Chugai Pharmaceutical Co., Ltd.
|
owl:sameAs |
http://www.wikidata.org/entity/Q750619 +
, http://ru.dbpedia.org/resource/Chugai_Pharmaceutical_Co. +
, http://ko.dbpedia.org/resource/%EC%A3%BC%EA%B0%80%EC%9D%B4_%EC%A0%9C%EC%95%BD +
, http://zh.dbpedia.org/resource/%E4%B8%AD%E5%A4%96%E8%A3%BD%E8%97%A5 +
, http://viaf.org/viaf/140015212 +
, http://d-nb.info/gnd/1086020138 +
, http://rdf.freebase.com/ns/m.03qk8lb +
, http://fa.dbpedia.org/resource/%DA%86%D9%88%DA%AF%D8%A7%DB%8C +
, http://yago-knowledge.org/resource/Chugai_Pharmaceutical_Co. +
, http://pl.dbpedia.org/resource/Chugai_Pharmaceuticals +
, http://de.dbpedia.org/resource/Ch%C5%ABgai_Seiyaku +
, http://dbpedia.org/resource/Chugai_Pharmaceutical_Co. +
, http://ja.dbpedia.org/resource/%E4%B8%AD%E5%A4%96%E8%A3%BD%E8%96%AC +
, https://global.dbpedia.org/id/4uhgn +
, http://viaf.org/viaf/312912422 +
, http://data.europa.eu/euodp/jrc-names/Chugai_Pharmaceutical_Co. +
, http://id.dbpedia.org/resource/Chugai +
, http://pt.dbpedia.org/resource/Chugai_Pharmaceutical_Co. +
, http://it.dbpedia.org/resource/Chugai +
|
rdf:type |
http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfJapan +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompanies +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/Company108058098 +
|
rdfs:comment |
주가이 제약 주식회사(일본어: 中外製薬株式会社, ちゅうがいせいやく)는 일본의 대형 제약 기업이며, 의약품 개발과 제조 및 수입한다.
, Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, … Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.epresentative director, president and CEO.
, La Chugai, chiamata ufficialmente Chugai P … La Chugai, chiamata ufficialmente Chugai Pharmaceutical Co. (中外 製 薬 株式会社 Chūgai Seiyaku Kabushikigaisha?), è una società giapponese produttrice di farmaci quotata alla borsa di Tokyo. È una filiale controllata dalla Hoffmann–La Roche, che dal 30 giugno 2014 detiene il 62% della società. giugno 2014 detiene il 62% della società.
, Chūgai Seiyaku Kabushiki kaisha (jap. 中外製薬株式会社; engl. Chugai Pharmaceutical Co., Ltd.) ist ein 1925 in Tokio gegründetes japanisches Pharmaunternehmen. Es ist im Nikkei 225 gelistet. Der registrierte Unternehmenssitz ist Kita, der tatsächliche Chūō.
, 中外製薬株式会社(ちゅうがいせいやく、英: CHUGAI PHARMACEUTICAL CO.,LTD.)は、日本の大手医薬品メーカーである。日経平均株価およびTOPIX Large70の構成銘柄の一つ。
, 中外製藥(日语:中外製薬/ちゅうがいせいやく Chūgai seiyaku */?)是一家日本製藥公司,目前為跨國藥廠羅氏的子公司。
, Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社 … Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社 Chūgai Seiyaku kabushiki gaisha) adalah produsen obat-obatan yang beroperasi di Jepang. Chugai adalah anak perusahaan yang dikendalikan oleh Hoffmann-La Roche, yang memiliki 62% saham perusahaan tersebut pada 30 Juni 2014. Perusahaan ini berkantor pusat di Tokyo. adalah direktur perwakilan dan ketua saat ini. Tatsuro Kosaka adalah direktur perwakilan, presiden, dan direktur utama saat ini.an, presiden, dan direktur utama saat ini.
, Chugai Pharmaceutical Co., Ltd. (яп. 中外 製 … Chugai Pharmaceutical Co., Ltd. (яп. 中外 製 薬 株式会社 Chūgai Seiyaku: кабусики-гайся) — японская фармацевтическая компания. Это дочерняя компания, контролируемая Hoffmann-La Roche, которой по состоянию на 30 июня 2014 года принадлежало 62% акции компании. Головной офис компании находится в Токио. Осаму Нагаяма – нынешний представитель директора и председатель. Тацуро Косака – нынешний представитель директора, президент и генеральный директор.ректора, президент и генеральный директор.
, Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社 Chūgai Seiyaku Kabushikigaisha?) é uma companhia farmacêutica japonesa, sediada em Tóquio.
, Chugai Pharmaceutical Co., Ltd. (jap. 中外製薬) – jeden z największych japońskich koncernów farmaceutycznych. 51,5% udziałów firmy należy do Hoffmann-La Roche. Koncern powstał w marcu 1943 roku.
|
rdfs:label |
Chugai Pharmaceutical Co.
, 中外製藥
, Chugai
, Chugai Pharmaceuticals
, 中外製薬
, Chūgai Seiyaku
, 주가이 제약
|